Q901 is a novel highly selective CDK7 inhibitor Q901 is ready for dose escalation study in the U.S. for the treatment of selected advanced solid tumors (NCT 05394103) The phase 1/2 study of Q901 and KEYTRUDA is designed to enroll patients with advanced solid tumors SEONGNAM-SI, South Korea–(BUSINESS WIRE)–#Qurient—Qurient Co. Ltd. (KRX: 115180), a clinical-stage … [Read more…]

GROTON, Conn.–(BUSINESS WIRE)–Astrocyte Pharmaceuticals Inc., a private drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, today provided an update on the preclinical and clinical development of its lead drug candidate, AST-004, in preclinical brain injury studies and in an ongoing clinical Phase 1 study. Theodore Liston, Ph.D., Vice President … [Read more…]

FRAMINGHAM, Mass.–(BUSINESS WIRE)–#autoimmune–Clinical Enterprise, Inc. d/b/a empowerDX, who offers the at-home Celiac Risk Gene Test, announced today that they have entered into an exclusive partnership with NIMA Partners, the makers of Gluten Sensor and Gluten Capsules for the detection of gluten in food particles. This partnership is characteristic of the ethos defining the mission of … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Susan Altschuller, Chief Financial Officer, will participate in a fireside chat at the upcoming Guggenheim Nantucket Therapeutics Conference. The presentation is scheduled for September 28, 2022 at 11:15am ET. A webcast … [Read more…]

Ventria’s success in excluding unfairly traded imports secures its ability to continue to invest in the next generation of plant biotechnology innovation JUNCTION CITY, Kan.–(BUSINESS WIRE)–#biotech—Ventria Bioscience Inc. (Ventria) today announced that the United States International Trade Commission (ITC) completed its review of Administrative Law Judge McNamara’s previous determination and affirmed the prior ruling that … [Read more…]

FRANKFURT, Germany–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it is advising PharmaLex Group (PharmaLex) on its pending sale to AmerisourceBergen. PharmaLex, a portfolio company of AUCTUS Capital Partners AG (AUCTUS), is a leading provider of specialized services for the pharma, biotech, and medtech industries worldwide. The transaction is being … [Read more…]

ST. LOUIS–(BUSINESS WIRE)–#Alzheimers–A group of distinguished Alzheimer’s disease researchers has affirmed, in a new study published online in the journal Brain, the superiority of the methods that are the basis of C2N Diagnostics’ new p[hospho]-tau217 ratio test. Currently available as a unique research tool in Alzheimer’s clinical studies, C2N’s p-tau217 ratio test is nearing completion … [Read more…]

Co-Created with Organicell, the first-to-market booster will address aging and inflammation through regenerative technology LONG BEACH, Calif.–(BUSINESS WIRE)–The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced a collaboration with biotech company Organicell to co-create a first-to-market exosome booster that will address signs of aging and inflammation in the skin. The booster will … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “HIPAA Texting and Emailing – Do’s and Don’ts” webinar has been added to ResearchAndMarkets.com’s offering. This lesson will be going into great detail regarding business information technology and how it relates to the HIPAA/HITECH Security Rule and securing PHI in transmission. Areas covered will be texting, email, encryption, medical messaging, voice data, personal … [Read more…]

Focus on technology and data to identify major trends and improve patient care AUSTIN, Texas & OTTAWA, Ontario–(BUSINESS WIRE)–ESO, a leading data and software company serving emergency medical services (EMS), fire departments, hospitals, state/provincial and national agencies, today announced a major partnership with the Paramedic Chiefs of Canada (PCC). The focus of the partnership will … [Read more…]